about
Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cellsBone regeneration and stem cellsDLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo.Potential of resveratrol analogues as antagonists of osteoclasts and promoters of osteoblasts.Pharmacological Inhibition of Protein Kinase G1 Enhances Bone Formation by Human Skeletal Stem Cells Through Activation of RhoA-Akt Signaling.Mesenchymal stem cells: cell biology and potential use in therapy.Serum levels of fetal antigen 1 in extreme nutritional StatesAssociation between in vivo bone formation and ex vivo migratory capacity of human bone marrow stromal cellsTelomerase activity promotes osteoblast differentiation by modulating IGF-signaling pathwayFA1 Induces Pro-Inflammatory and Anti-Adipogenic Pathways/Markers in Human Myotubes Established from Lean, Obese, and Type 2 Diabetic Subjects but Not Insulin Resistance.Human bone-marrow-derived mesenchymal stem cells: biological characteristics and potential role in therapy of degenerative diseases.Human mesenchymal stem cells: from basic biology to clinical applications.Estrogen inhibits Dlk1/FA1 production: a potential mechanism for estrogen effects on bone turnover.The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives.Marrow adipocytes inhibit the differentiation of mesenchymal stem cells into osteoblasts via suppressing BMP-signaling.Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis.New factors controlling the balance between osteoblastogenesis and adipogenesis.Skeletal (stromal) stem cells: an update on intracellular signaling pathways controlling osteoblast differentiation.DLK1 Regulates Whole-Body Glucose Metabolism: A Negative Feedback Regulation of the Osteocalcin-Insulin Loop.Mouse embryonic fibroblasts (MEF) exhibit a similar but not identical phenotype to bone marrow stromal stem cells (BMSC).Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity.CD34 defines an osteoprogenitor cell population in mouse bone marrow stromal cells.Selective isolation and differentiation of a stromal population of human embryonic stem cells with osteogenic potential.Mechanosensitivity of dental pulp stem cells is related to their osteogenic maturity.Isolation and differentiation of chondrocytic cells derived from human embryonic stem cells using dlk1/FA1 as a novel surface marker.The histopathology of a human mesenchymal stem cell experimental tumor model: support for an hMSC origin for Ewing's sarcoma?Osteoblast differentiation of NIH3T3 fibroblasts is associated with changes in the IGF-I/IGFBP expression pattern.Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females.Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation.Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene.Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation.Induction of adipocyte-like phenotype in human mesenchymal stem cells by hypoxia.Adult human mesenchymal stem cell as a target for neoplastic transformation.The use of hTERT-immortalized cells in tissue engineering.Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes.Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes.dlk1/FA1 regulates the function of human bone marrow mesenchymal stem cells by modulating gene expression of pro-inflammatory cytokines and immune response-related factors.Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-beta/activin/nodal signaling using SB-431542.Telomerase-deficient mice exhibit bone loss owing to defects in osteoblasts and increased osteoclastogenesis by inflammatory microenvironment.
P50
Q24336368-0A523D4D-020B-417A-95E2-7265EEE57AF4Q28659195-67F4F1A9-AF34-47A4-9148-63F428DE7119Q32874862-48EA020D-8DFF-4A91-8DC8-AE6FC2C3BCBDQ34173950-93DFCDD0-06FF-408E-B9B0-EABC4A19704BQ34242787-19E7BF57-42C7-47CC-856F-AC0D2AA37942Q35598732-56A381D1-4683-42D0-AAE9-62B8975C234AQ35951877-D3E57FBC-F781-45F1-942B-DD70A7E4482FQ36111492-1CA94A75-945B-492F-A6E9-8BDCA6A01399Q36141009-D070B847-D09E-4A00-9937-48D153E6873AQ36149431-139DFBD9-F30F-4154-AA34-0D3A5F4D9709Q36742652-60010B1D-8B62-4378-8BF0-E2EAAE1358A6Q36951714-6B888295-7493-4310-A1C6-D8E167402571Q36996120-C2A70710-D0BC-481C-B3E9-4AAC1AE89700Q37186728-B911662F-D667-44C4-8088-22648B727E82Q37252080-A1184B1B-C41B-475E-8788-707F6D4E240CQ37630840-6D9F173C-8129-4356-8293-74D0EAD85093Q37645107-F89DC9BA-7A20-4F7E-979D-6B1A60B96D98Q37899993-02550950-1515-4F45-BD1D-3AA211A0E6FBQ38241373-072D8AD3-8E23-4D1C-B13A-3DBE950BAC58Q38299429-9170F1B5-5441-45FF-813E-55E3B2548953Q38331808-542F1554-BDC1-4FF4-AB6E-07E147125F47Q38349700-17637AE2-DAF4-42E1-A80F-120E7C36D2F8Q38831926-A80BAEDE-E09E-4641-BF36-8FF500521E85Q39651691-928DBFF5-1550-420D-AB5C-5D956618C95EQ39739377-45F6B3F5-6295-4CF5-94D6-224523B26A07Q39754516-B5B42678-A5FF-423C-ACD4-647F5A3262AAQ39949387-EAE24CD2-F9B3-47DF-A9AB-11C3CD1E6E97Q40227573-038CF25A-DA43-40FA-A081-91F4F8AB9632Q40306429-FF67273B-52F8-4126-A029-4FF863BFCCB8Q40355275-C0AC6FBB-9359-4DCE-8098-C6C8DE33B312Q40439218-D9572068-6531-46AA-AA9D-B1E5964F8D40Q40481324-94342883-04F5-4900-904E-5E39FD354E63Q40484792-00020E29-D965-400C-B3F4-576D2EC53F97Q40563067-D3F3B376-67A3-43B5-AF0B-F93E99DA3A9EQ42206146-9E374C81-F7A5-49EF-B3A0-C3A45D0D5390Q42440646-D73E43A8-4996-4804-8BC3-7E45E3129B3CQ42484332-6E68239E-71FC-4627-9C91-B78E10AE9E75Q42505862-162E0455-0FBF-4AEA-9BFE-FB0C9B35ED7BQ43143526-FD24D80A-C331-49F6-A472-611E8EDFD19DQ44396602-D3D80789-EB14-4A59-AA59-28382DF2B7AB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Basem M Abdallah
@nl
Basem M Abdallah
@sl
Basem M. Abdallah
@en
Basem M. Abdallah
@es
type
label
Basem M Abdallah
@nl
Basem M Abdallah
@sl
Basem M. Abdallah
@en
Basem M. Abdallah
@es
altLabel
Basem Abdallah
@en
Basem M. Abdallah
@en
prefLabel
Basem M Abdallah
@nl
Basem M Abdallah
@sl
Basem M. Abdallah
@en
Basem M. Abdallah
@es
P1053
G-5667-2017
P106
P1153
6701715205
P213
0000 0003 5264 4804
P214
35145304384478571251
P2798
P31
P3829
P496
0000-0003-0324-8055
P735
P7859
viaf-35145304384478571251